RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/31942037http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/31942037http://www.w3.org/2000/01/rdf-schema#comment"Alzheimer's disease (AD) is the most common age-related form of dementia, associated with deposition of intracellular neuronal tangles consisting primarily of hyperphosphorylated microtubule-associated protein tau (p-tau) and extracellular plaques primarily comprising amyloid-β (Aβ) peptide. The p-tau tangle unit is a posttranslational modification of normal tau protein. Aβ is a neurotoxic peptide excised from the amyloid-β precursor protein (APP) by β-site APP-cleaving enzyme 1 (BACE1) and the γ-secretase complex. MicroRNAs (miRNAs) are short, single-stranded RNAs that modulate protein expression as part of the RNA-induced silencing complex (RISC). We identified miR-298 as a repressor of APP, BACE1, and the two primary forms of Aβ (Aβ40 and Aβ42) in a primary human cell culture model. Further, we discovered a novel effect of miR-298 on posttranslational levels of two specific tau moieties. Notably, miR-298 significantly reduced levels of ~55 and 50 kDa forms of the tau protein without significant alterations of total tau or other forms. In vivo overexpression of human miR-298 resulted in nonsignificant reduction of APP, BACE1, and tau in mice. Moreover, we identified two miR-298 SNPs associated with higher cerebrospinal fluid (CSF) p-tau and lower CSF Aβ42 levels in a cohort of human AD patients. Finally, levels of miR-298 varied in postmortem human temporal lobe between AD patients and age-matched non-AD controls. Our results suggest that miR-298 may be a suitable target for AD therapy."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.org/dc/terms/identifier"doi:10.1038/s41380-019-0610-2"xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Wang R."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Rinaldi C."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Lahiri D.K."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Beck J.S."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Chopra N."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Nho K."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Saykin A.J."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Pourshafie N."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Maloney B."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Counts S.E."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/author"Niculescu A."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/date"2021"xsd:gYear
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/name"Mol Psychiatry"xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/pages"5636-5657"xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/title"MicroRNA-298 reduces levels of human amyloid-beta precursor protein (APP), beta-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties."xsd:string
http://purl.uniprot.org/citations/31942037http://purl.uniprot.org/core/volume"26"xsd:string
http://purl.uniprot.org/citations/31942037http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/31942037
http://purl.uniprot.org/citations/31942037http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/31942037
http://purl.uniprot.org/uniprot/#_A0A0A0MRG2-mappedCitation-31942037http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31942037
http://purl.uniprot.org/uniprot/#_P56817-mappedCitation-31942037http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31942037
http://purl.uniprot.org/uniprot/#_A0A8F9R5D5-mappedCitation-31942037http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31942037
http://purl.uniprot.org/uniprot/#_A0A140VJC8-mappedCitation-31942037http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/31942037